PLIANT THERAPEUTICS, INC. Stock Issued During Period, Value, Employee Benefit Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, employee benefit plan for the quarter ending 2026-06-30 was $0.00.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, employee benefit plan for the quarter ending 2026-03-31 was $74.00K, a 85.14% decline year-over-year.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, employee benefit plan for the quarter ending 2025-09-30 was $72.00K, a 86.74% decline year-over-year.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, employee benefit plan for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, employee benefit plan for fiscal 2025 was $570.00K, a 82.23% decline from fiscal 2024.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, employee benefit plan for fiscal 2024 was $3.21M, a 35.89% decline from fiscal 2023.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, employee benefit plan for fiscal 2023 was $5.00M, a 267.79% increase from fiscal 2022.
- PLIANT THERAPEUTICS, INC. stock issued during period, value, employee benefit plan for fiscal 2022 was $1.36M, a 54.42% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Employee Benefit Plan 3 month | Stock Issued During Period, Value, Employee Benefit Plan 12 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $74.00K 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $570.00K 10-K · filed 2026-03-11 | |
| 2025-09-30 | $72.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $498.00K 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $3.21M 10-K · filed 2026-03-11 | |
| 2024-09-30 | $543.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $684.00K 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $1.88M 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $5.00M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $774.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $334.00K 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $3.66M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $1.36M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $808.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $446.00K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $51.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $2.98M 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |